Differences in radio-inhibitor binding characteristics of ACE from different rat tissues suggest the enzyme active site may not be identical across all organs.
Tissue-specific ACE binding in rats suggests possible active-site heterogeneity; leaves open whether this affects organ-selective inhibition in humans.
Angiotensin converting enzyme (ACE) derived from rat lung, aorta, epididymus, brain, kidney and plasma was characterized by radio-inhibitor (125I-MK351A) binding studies. Under optimal binding conditions at equilibrium 125I-MK351A bound to ACE was displaced from ACE in a concentration related manner by unlabelled MK351A. MK351A binding site concentration for each tissue and equilibrium dissociation constant (KD) was estimated by Scatchard analysis of binding data. Binding sites/mg protein was greatest in lung and least in brain. The KD for kidney ACE was significantly higher than that of lung, aorta, epididymus or brain ACE (P less than 0.005; t-test, d.f. = 10). 125I-MK351A bound to ACE prepared from lung and kidney was displaced in a concentration dependent manner by SQ20881, SQ14225, MK422, and Ro31-3113-000. Concentration of ACE inhibitor required to displace 50% of bound 125I-MK351A (DD50) was consistently higher for kidney-derived ACE than lung-derived ACE. The differences in radio-inhibitor binding characteristics of ACE from different rat tissues suggests that the enzyme active site may not be identical in all organs.
No takes yet. Share an insight, caveat, or question.
Jackson et al. (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: